Shadow Holdings DBA Bocchi Labs

Warning LetterOpen

United StatesIssued Feb 6, 2019

Letter not published by FDA

Source: FDA warning letter records. FDA has not published the text of this letter.

Violations0

Issue DateFeb 6, 2019

Product TypeOther

StatusOpen

Letter Details

Firm: Shadow Holdings DBA Bocchi Labs
Location: United States
FEI Number: N/A
Country: United States
Issue Date: February 06, 2019
Issuing Office: N/A
Product Type: Other
Status: Open

Summary

Based on limited metadata, this warning letter was issued to Shadow Holdings, operating as Bocchi Labs, on February 6, 2019. The letter pertains to a product categorized as "Other," though the specific nature of the violations cannot be determined as no subject line or detailed information is available. Without access to the full warning letter text or identifying information about the issuing office, the specific regulatory requirements violated and the product category details remain unclear.

Shadow Holdings DBA Bocchi Labs FDA Warning Letter, February 6, 2019